White Paper

Design Testing Strategies To Develop A Drug-Device Combination Product

GettyImages-1441662840-lab-team-communication-collaboration

Commercializing a drug-device combination product is a complex challenge to handle alone. Even though a variety of auto-injectors, pen injectors and wearable devices already exist, each one may react differently to your drug product so careful review is required to develop an optimal Validation Master Plan.

Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products. With the right guidance and execution, you can carefully review and develop a Validation Master Plan to ensure optimal results. Testing involves comparing different brands or quality levels to determine the best container and device combination.

Stevanato Group offers various methods for testing drug-device combination products and can handle a wide range of drug products, including controlled substances. They also provide test method transfer protocols and forensic capabilities to identify failures. With their design and manufacturing capabilities, they offer technical analysis and generate regulatory documents.

Learn more about the importance of developing and optimized Validation Master Plan and how an experienced partner like Stevanato Group can help develop and execute the plan, starting with determining what components to test and what methods to use.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online